BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1724192)

  • 1. [Perioperative chemotherapy of stomach cancer].
    Preusser P; Wilke H; Fink U; Meyer HJ; Bünte H; Siewert JR
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():125-8. PubMed ID: 1724192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of advanced stomach carcinoma. Current study concepts].
    Kuhn R; Ridwelski K
    Zentralbl Chir; 2000; 125 Suppl 2():176-81. PubMed ID: 11190641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stomach carcinoma. Optimizing therapy by neoadjuvant or adjuvant therapy?].
    Rosen H
    Zentralbl Chir; 1999; 124(5):387-93. PubMed ID: 10420523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric cancer in the elderly: an overview.
    Saif MW; Makrilia N; Zalonis A; Merikas M; Syrigos K
    Eur J Surg Oncol; 2010 Aug; 36(8):709-17. PubMed ID: 20542657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of surgery in the patients with stage I and II primary gastric lymphoma.
    Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
    Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neo-adjuvants, adjuvants and palliative therapy for gastric carcinoma].
    Klein HO
    Praxis (Bern 1994); 1998 Mar; 87(13):451-4. PubMed ID: 9584571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of immunochemo-surgery for gastric carcinoma.
    Kim JP; Yu HJ; Lee JH
    Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy in gastric cancer.
    Wöll E; Devries A; Eisterer W; Hejna M; Keil F; Stein H; Zacherl J; Greil R
    Anticancer Res; 2008; 28(2B):1213-9. PubMed ID: 18505058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends and controversies in the management of carcinoma of the stomach.
    Adam YG; Efron G
    Surg Gynecol Obstet; 1989 Oct; 169(4):371-85. PubMed ID: 2476864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preoperative (neoadjuvant) chemotherapy in multimodality treatment concept of stomach carcinoma].
    Meyer HJ; Jähne J; Wilke H; Pichlmayr R
    Zentralbl Chir; 1995; 120(2):128-34. PubMed ID: 7709664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palliative gastrectomy and other factors affecting overall survival in stage IV gastric adenocarcinoma patients receiving chemotherapy: a retrospective analysis.
    Sougioultzis S; Syrios J; Xynos ID; Bovaretos N; Kosmas C; Sarantonis J; Dokou A; Tzivras D; Zografos G; Felekouras E; Papalambros E; Tsavaris N
    Eur J Surg Oncol; 2011 Apr; 37(4):312-8. PubMed ID: 21300519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The German EORTC Study of neoadjuvant therapy of stomach carcinoma].
    Siewert JR; Schuhmacher C; Fink U
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():717-9. PubMed ID: 9931709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regional chemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial.
    Lygidakis NJ; Sgourakis G; Aphinives P
    Hepatogastroenterology; 1999; 46(27):2035-8. PubMed ID: 10430393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of self-expandable metallic stent plus chemotherapy for metastatic gastric cancer with pyloric stenosis.
    Shimura T; Kataoka H; Sasaki M; Yamada T; Hayashi K; Togawa S; Okumura F; Kubota E; Ohara H; Joh T
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1358-64. PubMed ID: 19467141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical profile of carcinoma stomach at a tertiary care hospital in south India.
    Sambasivaiah K; Ibrarullah M; Reddy MK; Reddy PV; Wagholikar G; Jaiman S; Reddy DG; Sarma KV; Hegde GN
    Trop Gastroenterol; 2004; 25(1):21-6. PubMed ID: 15303466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study.
    Persiani R; Rausei S; Pozzo C; Biondi A; Barone C; Cananzi FC; Schinzari G; D'Ugo D
    Ann Surg Oncol; 2008 Aug; 15(8):2146-52. PubMed ID: 18543037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy for advanced gastric cancer--our possibilities in 2007].
    Dank M; Torgyík L; Szentmártoni G
    Magy Onkol; 2007; 51(3):209-17. PubMed ID: 17922060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy.
    Becker K; Mueller JD; Schulmacher C; Ott K; Fink U; Busch R; Böttcher K; Siewert JR; Höfler H
    Cancer; 2003 Oct; 98(7):1521-30. PubMed ID: 14508841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.